3 minute read

Partnerships and Collaborations

Australian/New Zealand Partnerships and Collaborations

ANZUP is proud of its collaborations and relationships with a wide range of research organisations.

Prostate Cancer Foundation of Australia (PCFA)

In March 2016 ANZUP and the Prostate Cancer Foundation of Australia (PCFA) signed a formal agreement to improve access to clinical trials, pledging to work together to raise $1.5 million over three years to fund prostate clinical trials. Thanks to this partnership grant, ANZUP and PCFA are set to launch a landmark prostate cancer trial together in the second half of 2017.

In addition, PCFA will continue to be a Platinum Sponsor of the ANZUP Annual Scientific Meeting and will host PCFA’s annual Prostate Cancer Specialist Nursing Conference in conjunction with the ASM.

We are most grateful to PCFA’s Chairman Mr Jim Hughes AM and CEO Associate Professor Anthony Lowe for their efforts in progressing this exciting new initiative.

Cancer Cooperative Trials Groups (CCTGs)

As well as running co-badged trials with other CCTGs, ANZUP is also a member of the Executive Officers Network (EON), which provides a forum for sharing resources and ideas that builds stronger links between the CCTGs. From this network, we have also established a Clinical Trials Consumer Network (CTCN).

NHMRC Clinical Trials Centre (CTC) at the University of Sydney

ANZUP collaborates with CTC to conduct a number of our clinical trials to achieve quality processes on trial development and operations. We value the close working relationship we have with CTC and acknowledge and thank staff at CTC.

Centre for Biostatistics and Clinical Trials (BaCT) at Peter MacCallum Cancer Centre

We have also established a collaboration with BaCT to coordinate two of our ANZUP studies – a Muscle Invasive Bladder Cancer (PCR-MIB) study; and a newly funded nonclear cell renal carcinoma study (UNISoN). Based at Peter Mac, BaCT provides and coordinates statistical, regulatory and informatics support in the design, planning, conduct, analysis and reporting of clinical research studies.

International Partnerships and Collaborations:

• Alliance for Clinical Trials in Oncology • Canadian Cancer Trials Group • Cancer Trials Ireland • Children’s Oncology Group (COG) • European Organisation for Research and Treatment of

Cancer (EORTC) • Dana Faber Cancer Institute • Medical Research Council (MRC) UK • Prostate Cancer Clinical Trials Consortium (PCCTC)

Other key relationships

• Australian Clinical Trials Alliance (ACTA) • Cancer Australia • Clinical Oncology Society of Australia (COSA) • USANZ • Cancer Councils • Movember

• Kidney Health Australia

MARTIN STOCKLER, SCOTT WILLIAMS, IAN DAVIS, MARG MCJANNETT, SIMON CHOWDERY, OLWYN DEIGNAN AND PAUL KELLY AT THE ITSC MEETING

CORPORATE SUPPORTERS

We are very fortunate to have our corporate supporters and partners who enable ANZUP to better support our members and, ultimately, patients and their families. Our 2016/17 corporate supporters include:

Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Ipsen, Janssen, Novartis, Sanofi, and Tolmar Australia.

KIND-INKIND

We acknowledge and thank the following organisations for the generosity they have shown by providing their services pro-bono.

Active Display Group, Air New Zealand, Bloke, Ferguson Cannon Lawyers and The Saturday Paper.

This article is from: